NCT03771352View on ClinicalTrials.gov

Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism

NACompletedINTERVENTIONAL
Enrollment

55

Participants

Timeline

Start Date

June 19, 2018

Primary Completion Date

July 1, 2019

Study Completion Date

July 1, 2020

Conditions
Cataract
Interventions
DEVICE

RxSight RxLAL

The patients will be assessed for 6 months

Trial Locations (3)

Unknown

University Eye Clinic, Bochum

University Eye Clinic, Heidelberg

Ayrshire Eye Clinic and Laser Center, Ayr

All Listed Sponsors
lead

RxSight, Inc.

INDUSTRY

NCT03771352 - Clinical Study to Evaluate the RxSight Light Adjustable Lens With the Light Delivery Device in Subjects With Preoperative Corneal Astigmatism | Biotech Hunter | Biotech Hunter